OFFICIAL ROYAL PEPTIDES WEBSITE You are on royal-peptides.com
VERIFY OFFICIAL SITE

Royal Peptides

ROYAL RESEARCH CATALOG

Selank + Semax Blend 20mg Exclusive Royal custom Blend🔥

Research Material Batch Documentation Secure Checkout
Price range: $90 through $685
Choose an option
Clear selection
01Research focusedLaboratory research materials
02DocumentedAvailable batch information
03TrackedOrder fulfillment updates
Secure payment VISA link $ ₿
RESEARCH NOTICE
For laboratory and research purposes only.Not intended for human consumption, diagnostic use, therapeutic use, or administration to humans or animals.
View Documentation →
Dual-Peptide Research Blend

Selank + Semax 20 mg Research Peptide Blend

A defined dual-component research formulation containing Selank 10 mg and Semax 10 mg in a single 20 mg lyophilized research vial. The formulation combines two distinct synthetic heptapeptides for controlled multi-component peptide research.

Selank 10 mg Semax 10 mg 20 mg Total 1:1 Blend Dual Heptapeptide Batch Traceability
Research Use Only

Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use.

01
Blend Profile

Selank + Semax Research Material

The Selank + Semax 20 mg blend is a defined two-component research formulation containing equal quantities of two structurally distinct synthetic heptapeptides.

Selank is structurally related to the tuftsin peptide sequence, while Semax is structurally associated with an ACTH-derived peptide fragment. Both contain seven amino-acid residues but maintain separate molecular identities within the blend.

Royal Peptides supplies this formulation exclusively as a laboratory research material for controlled analytical and experimental investigation.

02
Defined Composition

10 mg Selank + 10 mg Semax

The 20 mg vial contains a defined 1:1 composition by labeled peptide mass, providing equal quantities of Selank and Semax within a single research formulation.

Component 01 Selank 10 mg

Synthetic heptapeptide structurally derived from a tuftsin-related peptide sequence.

Component 02 Semax 10 mg

Synthetic heptapeptide structurally associated with an ACTH-derived peptide fragment.

TOTAL LABELED PEPTIDE CONTENT  •  20 mg
03
Component Identification

Two Distinct Heptapeptides

Selank 10 mg Heptapeptide component
Selank Sequence TKPRPGP Thr-Lys-Pro-Arg-Pro-Gly-Pro
Semax 10 mg Heptapeptide component
Semax Sequence MEHFPGP Met-Glu-His-Phe-Pro-Gly-Pro
Selank Component

Selank provides one defined seven-residue peptide sequence within the formulation and retains its individual compound identity for analytical research.

Semax Component

Semax provides a separate seven-residue peptide sequence within the formulation and remains analytically distinct from Selank.

Shared PGP Terminus

Both peptide sequences contain a Pro-Gly-Pro sequence at their C-terminal region, providing a useful structural feature for comparative laboratory investigation.

Defined 1:1 Composition

Equal labeled quantities provide a controlled dual-component material for experiments requiring a predefined Selank-to-Semax ratio.

04
Scientific Context

Controlled Multi-Component Research

Selank and Semax have individually appeared in experimental literature involving peptide-associated molecular and neurobiological systems. A blended material can support controlled research designs where both defined peptide components are evaluated within the same experimental system.

Comparative Peptide Research

Researchers may investigate structural or analytical similarities and differences between the two defined heptapeptide components.

Molecular Signaling Models

Controlled experimental systems may examine measurable molecular variables associated with peptide signaling pathways.

Multi-Component Analysis

The formulation provides a defined dual-component material for analytical methods designed to distinguish or quantify multiple peptide constituents.

Structure-Function Research

The distinct parent sequences together with their shared Pro-Gly-Pro terminal motif provide structural variables for controlled comparative investigation.

05
Analytical Documentation

Batch-Specific Research Information

Laboratory evaluation should rely on analytical documentation corresponding to the specific production lot received. For a multi-component formulation, researchers should distinguish between total labeled material quantity and the identity or measured content of each individual peptide component.

  • Selank component identification
  • Semax component identification
  • Production lot or batch reference
  • Declared 10 mg + 10 mg composition
  • Analytical testing information
  • Purity information where applicable
  • Testing methodology where documented
  • Batch-specific documentation where available
06
Traceability

Research Records & Batch Control

Appropriate research records should connect experimental observations to the specific Selank + Semax production lot incorporated into the laboratory workflow.

Blend Identification

Record the formulation name, individual component quantities, total labeled quantity, production lot, date received, and applicable internal laboratory identifier.

Analytical Records

Preserve applicable analytical documentation, experimental observations, results, material-control records, and other records associated with the specific research lot.

07
Laboratory Protocol

Handling & Storage

Selank + Semax research material should be handled using appropriate laboratory procedures intended to preserve material identity, minimize contamination, and maintain experimental traceability.

Laboratory Handling

Maintain clear identification of the dual-component material throughout receipt, storage, analytical preparation, and experimental workflows.

Storage & Documentation

Follow storage information associated with the applicable product label and batch documentation rather than relying on generalized storage claims.

08
Important Restrictions

Research Use Limitations

Royal Peptides Selank + Semax 20 mg is supplied exclusively as a laboratory research material. It is not offered or represented as a medicine, pharmaceutical preparation, dietary supplement, food, cosmetic, or consumer health product.

  • Not for human administration
  • Not for veterinary administration
  • Not for ingestion or injection
  • Not for personal experimentation
  • Not for pharmaceutical compounding
  • Not for pharmacy preparation
  • Not for diagnostic or therapeutic use
  • Not for clinical use
09
Research FAQ

Selank + Semax Blend Questions

What is in the Selank + Semax 20 mg blend?

The formulation contains 10 mg of Selank and 10 mg of Semax, providing 20 mg total labeled peptide material in a 1:1 ratio.

Is Selank + Semax a single peptide?

No. It is a blend containing two separate synthetic heptapeptides. Selank and Semax retain distinct amino-acid sequences and molecular identities.

What is the Selank sequence?

Selank is commonly identified as Thr-Lys-Pro-Arg-Pro-Gly-Pro, abbreviated TKPRPGP.

What is the Semax sequence?

Semax is commonly identified as Met-Glu-His-Phe-Pro-Gly-Pro, abbreviated MEHFPGP.

How are Selank and Semax structurally different?

Selank is structurally related to a tuftsin-derived peptide sequence, while Semax is associated with an ACTH-derived peptide fragment. They are distinct compounds despite both being seven-residue peptides.

What do Selank and Semax have in common?

Both are synthetic heptapeptides and both contain a Pro-Gly-Pro sequence at their C-terminal region. Their remaining sequences and structural origins differ.

Is the blend intended for human use?

No. Royal Peptides supplies this formulation strictly for laboratory research. It is not intended for human or veterinary administration.

Does Royal Peptides provide dosing instructions?

No. Royal Peptides does not provide dosing, administration, injection, prescribing, treatment, or personal-use instructions for this research material.

Is analytical documentation available?

Batch-specific analytical documentation may be available for the applicable production lot. Researchers should review documentation corresponding to the specific material received.

Research Use Only

Dual-Component Laboratory Research Material

Selank + Semax 20 mg is supplied for laboratory research use only. Not for human or veterinary use. Not intended for administration, ingestion, injection, personal experimentation, pharmaceutical compounding, pharmacy preparation, diagnostic use, therapeutic use, or clinical use. Nothing on this page constitutes medical advice or represents this research material as intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

0